Comments
Loading...

Day One Biopharmaceutical

DAWNNASDAQ
Logo brought to you by Benzinga Data
$13.72
0.382.85%
At close: -
$13.98
0.261.90%
After Hours: Nov 22, 7:42 PM EDT

Day One Biopharmaceutical (NASDAQ:DAWN) Stock, Earnings Estimates, EPS, And Revenue

Day One Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 24
EPS Estimate
$-0.640
Quarterly Revenue Estimate
$15.9M
Annual Revenue
(as of Sep 30)
$102M

Analyze the earnings history of Day One Biopharmaceutical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Day One Biopharmaceutical (DAWN) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-30$0.38$-0.41192.7 %
Jun 20242024-07-30$-0.05$-0.6291.9 %
Mar 20242024-05-06$-0.72$-0.66-9.09 %
Dec 20232024-02-26$-0.64$-0.58-10.3 %

Day One Biopharmaceutical (DAWN) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-10-30$93.76M$23.54M298.3 %
Jun 20242024-07-30$8.19M$1.02M703.1 %

FAQ

Q

When is Day One Biopharmaceutical (NASDAQ:DAWN) reporting earnings?

A

Day One Biopharmaceutical (DAWN) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Day One Biopharmaceutical (NASDAQ:DAWN)?

A

The Actual EPS was $0.38, which beat the estimate of $-0.41.

Q

What were Day One Biopharmaceutical’s (NASDAQ:DAWN) revenues?

A

The Actual Revenue was $93.8M, which beat the estimate of $23.5M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch